Detection of specific antibodies for bladder cancer

• Project/Area Number: 24592408
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Research Field: Urology
• Research Institution: Kitasato University
• Principal Investigator: MATSUMOTO Kazumasa 北里大学, 医学部, 講師 (70306603)
• Co-Investigator(Kenkyū-buntansha): SATO Yuichi 北里大学, 医療衛生学部, 教授 (30178793) ; SATOH Takefumi 北里大学, 医学部, 講師 (50286332)
• Project Period (FY): 2012-04-01 – 2015-03-31
• Project Status: Completed (Fiscal Year 2014)
• Budget Amount: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000); Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000); Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000); Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
• Keywords: 膀胱癌 / 尿路上皮癌 / 蛋白解析 / 腫瘍マーカー / 蛋白質 / プロテオーム解析 / スクリーニング

Outline of Final Research Achievements

The purpose of this study was to establish the diagnostic tools for bladder cancer using patients’ samples including blood and urine. We detected many monoclonal and autoimmune antibodies for bladder cancer in pathologic tissues and serum. We also found that these proteins were associated with clinicopathologic findings and prognosis. For example, the expression of nestin in bladder cancer tissues was associated with higher pathologic stage and poorer prognosis. Serum S100A6 was significant higher in non-muscle invasive bladder cancer than in controls. In additions, autoimmune antibodies of MMP2 and calreticulin were significantly increased in patients with bladder cancer compared to in controls. We will plan to examine whether the rest of bladder specific proteins detected in this project would be matched in real world clinical scenario.

Research Products

• [Journal Article] High expression level of preoperative serum uroplakin III is associated with biologically aggressive bladder cancer. (2015)
  • Author(s): Tsumura H, Matsumoto K, Ikeda M, Yanagita K, Hirano S, Hagiwara M, Nagashio R, Fujita T, Sato Y, Iwamura M.
  • Journal Title: Asian Pac J Cancer Prev. Volume: 16 Pages: 1539-1543
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] Conditional survival after radical nephroureterectomy for upper tract carcinoma. (2015)
  • Author(s): Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Roupret M, Matsumoto K, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W.
  • Journal Title: Eur Urol. Volume: 67 Issue: 4 Pages: 803-812
  • DOI: 10.1016/j.eururo.2014.08.003
  • Peer Reviewed
• [Journal Article] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castrate-resistant prostate cancer: dose-related immune boosting and suppression. (2015)
  • Author(s): Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A, Itoh K.
  • Journal Title: Cancer Immunol Immunother. Volume: 64 Issue: 4 Pages: 493-505
  • DOI: 10.1007/s00262-015-1660-1
  • Peer Reviewed
• [Journal Article] Gemcitabine plus nedaplatin as salvage therapy is a favorable option for patients with progressive metastatic urothelial carcinoma after two lines of chemotherapy. (2015)
  • Author(s): Matsumoto K, Mochizuki K, Hirayama T, Ikeda M, Nishi M, Tabata K, Okazaki M, Fujita T, Taoka Y, Iwamura M.
  • Journal Title: Asian Pac J Cancer Prev. Volume: 16 Pages: 2483-2487
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] Clinical value of dividing false positive urine cytology findings into three categories: atypical, indeterminate and suspicious of malignancy. (2014)
  • Author(s): Matsumoto K, Ikeda M, Hirayama M, Nishi M, Fujita T, Hattori M, Sato Y, Ohbu M, Iwamura M.
  • Journal Title: Asian Pac J Cancer Prev. Volume: 15 Pages: 2251-2255
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder. (2014)
  • Author(s): Tabata K, Matsumoto K, Minami S, Ishii D, Nishi M, Fujita T, Saegusa M, Sato Y, Iwamura M.
  • Journal Title: PLOS ONE Volume: 9 (5) Issue: 5 Pages: e91548-e91548
  • DOI: 10.1371/journal.pone.0091548
  • Peer Reviewed / Open Access
• [Journal Article] Predictors of survival in patients with disease recurrence after radical nephroureterectomy. (2014)
  • Author(s): Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Roupret M, Tagawa ST, Chun FK, Scherr DS, Vickers A, Shariat SF.
  • Journal Title: BJU Int. Volume: 113 Issue: 6 Pages: 911-917
  • DOI: 10.1111/bju.12369
  • Peer Reviewed
• [Journal Article] Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder. (2014)
  • Author(s): Matsumoto K, Ikeda M, Sato Y, Kuruma H, Kamata Y, Nishimori T, Tomonaga T, Nomura F, Egawa S, Iwamura M.
  • Journal Title: Biomed Res. Volume: 35 Pages: 201-206
  • NAID: 130004470868
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. (2014)
  • Author(s): Xylinas E, Kluth LA, Rieken M, Lee RK, Elghouayel M, Ficarra V, Margulis V, Lotan Y, Roupret M, Martinez-Salamanca JI, Matsumoto K, Seitz C, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF.
  • Journal Title: BJU Int. Volume: 114 Issue: 1 Pages: 56-61
  • DOI: 10.1111/bju.12400
  • Peer Reviewed
• [Journal Article] Comparison of radical cystectomy and chemoradiotherapy in patients with locally advanced bladder cancer. (2014)
  • Author(s): Ikeda M, Matsumoto K, Nishi M, Tabata K, Fujita T, Ishiyama H, Hayakawa K, Iwamura M.
  • Journal Title: Asian Pac J Cancer Prev. Volume: 15 Pages: 6519-6524
  • Peer Reviewed / Open Access
• [Journal Article] Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. (2014)
  • Author(s): Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K, Kikuchi E, Klatte T, Boorjian SA, Lotan Y, Roghmann F, Fairey AS, Fradet Y, Black PC, Rendon R, Izawa J, Kassouf W.
  • Journal Title: Eur Urol. Volume: 66 Issue: 2 Pages: 361-370
  • DOI: 10.1016/j.eururo.2013.09.050
  • Peer Reviewed
• [Journal Article] Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014)
  • Author(s): Rieken M, Schubert T, Xylinas E, Kluth L, Roupret M, TrinhQD, Lee RK, Al Hussein Al Awamlh B, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF.
  • Journal Title: Eur J Surg Oncol. Volume: 40 Issue: 12 Pages: 1693-1699
  • DOI: 10.1016/j.ejso.2014.03.018
  • Peer Reviewed
• [Journal Article] Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder. (2014)
  • Author(s): Matsumoto K, Ikeda M, Matsumoto T, Nagashio R, Nishimori T, Tomonaga T, Nomura F, Sato Y, Kitasato H, Iwamura M.
  • Journal Title: Asian Pac J Cancer Prev. Volume: 15 Pages: 9927-9931
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] <b>Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary </b><b>bladder </b> (2014)
  • Author(s): Nishi M, Matsumoto K, Kobayashi M, Yanagita K, Matsumoto T, Ryo Nagashio, Ishii D, Fujita T, Sato Y, Iwamura M.
  • Journal Title: Biomedical Research Volume: 35 Issue: 6 Pages: 351-356
  • DOI: 10.2220/biomedres.35.351
  • NAID: 130004903871
  • ISSN: 0388-6107, 1880-313X
  • Peer Reviewed / Open Access / Acknowledgement Compliant
• [Journal Article] Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma (2014)
  • Author(s): M. Rieken,E. Xylinas,L. Kluth,Q.-D. Trinh,R.K. Lee, H. Fajkovic,G. Novara,V. Margulis,Y. Lotan, J.I. Martinez-Salamanca,K. Matsumoto,C. Seitz, M. Remzi,P.I. Karakiewicz,D.S. Scherr,A. Briganti, A. Kautzky-Willer,A. Bachmann,S.F. Shariat
  • Journal Title: European Journal of Surgical Oncology Volume: 40 Issue: 1 Pages: 113-120
  • DOI: 10.1016/j.ejso.2013.09.016
  • Peer Reviewed
• [Journal Article] Detection of tumor-associated antigens in culture supernatants using autoantibodiesin sera from patients with bladder cancer (2014)
  • Author(s): Minami S, Nagashio R, Ueda J, Matsumoto K, Goshima N, Hattori M, Hachimura K, Iwamura M, Sato Y.
  • Journal Title: Biomedical Research Volume: 35 Issue: 1 Pages: 25-35
  • DOI: 10.2220/biomedres.35.25
  • NAID: 130004903857
  • ISSN: 0388-6107, 1880-313X
  • Peer Reviewed
• [Journal Article] Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy (2013)
  • Author(s): Michael Rink,Evanguelos Xylinas,Vitaly Margulis, Eugene K. Cha,Behfar Ehdaie,Jay D. Raman,Felix K. Chun,Kazumasa Matsumoto,Yair Lotan,Helena Furberg, Marek Babjuk,Armin Pycha,Christopher G. Wood,Pierre I. Karakiewicz,Margit Fisch,Douglas S. Scherr,Shahrokh F. Shariat
  • Journal Title: EUROPEAN UROLOGY Volume: 63 Issue: 6 Pages: 1082-1090
  • DOI: 10.1016/j.eururo.2012.06.029
  • Peer Reviewed
• [Journal Article] Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resection. (2013)
  • Author(s): Tsumura H, Matsumoto K, Sato Y, Ikeda M, Fujita T, Satoh T, Iwamura M.
  • Journal Title: Mol Clin Oncol Volume: １ Issue: 3 Pages: 473-479
  • DOI: 10.3892/mco.2013.92
  • Peer Reviewed
• [Journal Article] C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib (2012)
  • Author(s): Tetsuo Fujita, Masatsugu Iwamura, Daisuke Ishii, Kenichi Tabata, Kazumasa Matsumoto,Kazunari Yoshida, Shiro Baba
  • Journal Title: INTERNATIONAL JOURNAL OF UROLOGY Volume: 19(10) Pages: 908-913
  • NAID: 10031123326
  • Peer Reviewed
• [Journal Article] A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guérin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial (2012)
  • Author(s): Kazumasa Matsumoto,Akira Irie,Hiroaki Inatsuchi,Yasuo Ogata, et al.,
  • Journal Title: JAPANESE JOURNAL OF CLINICAL ONCOLOGY Volume: 42(9) Pages: 813-819
  • Peer Reviewed
• [Journal Article] Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma (2012)
  • Author(s): Hans-Martin Fritsche,Giacomo Novara,Maximilian Burger,Amit Gupta,Kazumasa Matsumoto,Wassim Kassouf,et al.,
  • Journal Title: Urologic Oncology: Seminars and Original Investigations Volume: 30(5) Pages: 666-672
  • Peer Reviewed
• [Journal Article] International validation of the prognostic value of subclassifi cation for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis (2012)
  • Author(s): Marco Roscigno,Eugene K. Cha,Michael Rink,Christian Seitz, Giacomo Novara,Thomas F. Chromecki,Hans-Martin Fritsche, Kazumasa Matsumoto,Thomas J. et al.,
  • Journal Title: BJU INTERNATIONAL Volume: 110(5) Pages: 674-681
  • Peer Reviewed
• [Journal Article] Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy (2012)
  • Author(s): Faysal A. Yafi,Giacomo Novara,Shahrokh F. Shariat, Amit Gupta,Kazumasa Matsumoto,et al.,
  • Journal Title: BJU INTERNATIONAL Volume: 110(2b)
  • Peer Reviewed
• [Journal Article] Cytological Significance of Abnormal Squamous Cells in Urinary Cytology (2012)
  • Author(s): Manabu Hattori,Yukari Nishimura,Masumi Toyonaga,Hirokuni Kakinuma,Kazumasa Matsumoto,Makoto Ohbu
  • Journal Title: DIAGNOSTIC CYTOPATHOLOGY Volume: 40(9) Pages: 798-803
  • Peer Reviewed
• [Presentation] Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. (2015)
  • Author(s): Xylinas EN, Kluth LA, Rieken M, Scherr DS, Margulis V, Lotan Y, Martinez-Salamanca J, Matsumoto K, Karakiewica PI, Shariat SF.
  • Organizer: 30th Annual European Association of Urology Congress
  • Place of Presentation: Madrid(スペイン)
  • Year and Date: 2015-03-20 – 2015-03-24
• [Presentation] Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer. (2015)
  • Author(s): Mochizuki K, Matsumoto K, Minami S, Tabata K, Fujita T, Irie A, Yoshida K, Sato Y, Iwamura M.
  • Organizer: 30th Annual European Association of Urology Congress
  • Place of Presentation: Madrid(スペイン)
  • Year and Date: 2015-03-20 – 2015-03-24
• [Presentation] Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder. (2015)
  • Author(s): Matsumoto K, Hirayama T, Ikeda M, Nishi M, Tsumura H, Fujita T, Irie A, Yoshida K, Sato Y, Iwamura M.
  • Organizer: 30th Annual European Association of Urology Congress
  • Place of Presentation: Madrid(スペイン)
  • Year and Date: 2015-03-20 – 2015-03-24
• [Presentation] 尿路上皮がんにおける腫瘍マーカーの探索 (2015)
  • Author(s): 松本和将
  • Organizer: 第１２回北里疾患プロテオーム研究会・第６５回日本電気泳動学会シンポジウム
  • Place of Presentation: 北里大学(神奈川県相模原市)
  • Year and Date: 2015-03-18
  • Invited
• [Presentation] Salvage chemotherapy としてのGemcitabine/Nedaplatin療法の検討 (2014)
  • Author(s): 松本和将、池田勝臣、平山貴博、西 盛宏、田畑健一、藤田哲夫、岩村正嗣
  • Organizer: 第５２回日本癌治療学会学術集会
  • Place of Presentation: パシフィコ横浜(神奈川県横浜市)
  • Year and Date: 2014-08-28 – 2014-08-30
• [Presentation] 化学療法抵抗性膀胱がんに対しするがんワクチン療法の第II相無作為比較試験 (2014)
  • Author(s): 野口正典、松本和将、植村天寿、新井 学、江藤正俊、内藤誠二、大山 力、那須保友、田中正利、伊東恭悟
  • Organizer: 第５２回日本癌治療学会学術集会
  • Place of Presentation: パシフィコ横浜(神奈川県横浜市)
  • Year and Date: 2014-08-28 – 2014-08-30
• [Presentation] Randomized phase II study of personalized peptide vaccination in patients with advanced bladder cancer progressing after chemotherapy. (2014)
  • Author(s): Noguchi M, Matsumoto K, Uemura H, Arai G, Etoh M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu M, Sasada T, Yamada A, Itoh K.
  • Organizer: 50th Annual Meeting of the American Society of Clinical Oncology
  • Place of Presentation: Chicago(アメリカ合衆国)
  • Year and Date: 2014-05-30 – 2014-06-03
• [Presentation] Association of perioperative blood transfusion with oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014)
  • Author(s): Rieken M, Schubert T, Xylinas E, Kluth L, Roupret M, Trinh QD, Lee R, Awamlh AI, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remz M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF.
  • Organizer: 107th Annual Meeting American Urological Association
  • Place of Presentation: Orlando(アメリカ合衆国)
  • Year and Date: 2014-05-16 – 2014-05-21
• [Presentation] 尿細胞診擬陽性症例に対する臨床的評価について (2014)
  • Author(s): 松本和将、平山貴博、池田勝臣、西 盛宏、田畑健一、藤田哲夫、服部 学、大部誠、岩村正嗣
  • Organizer: 第１０２回日本泌尿器科学会総会
  • Place of Presentation: 神戸国際会議場(兵庫県神戸市)
  • Year and Date: 2014-04-24 – 2014-04-27
• [Presentation] Association of perioperative blood transfusion with oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. (2014)
  • Author(s): Rieken M, Schubert T, Xylinas E, Kluth L, Roupret M, Trinh QD, Lee RK, Awamlh AI, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remz M, Karakiewicz PI, Scherr DS, Briganti A, Bachmann A, Shariat SF.
  • Organizer: 29th Annual European Association of Urology Congress
  • Place of Presentation: Stockholm(スウェーデン)
  • Year and Date: 2014-04-11 – 2014-04-16
• [Presentation] Increased expression of serum uroplakin III is associated with the detection and pathological features of aggressive bladder cancer. (2014)
  • Author(s): Tsumura H, Matsumoto K, Matsumoto T, Ikeda M, Satoh T, Yoshida K, Sato Y, Iwamura M.
  • Organizer: 29th Annual European Association of Urology Congress
  • Place of Presentation: Stockholm(スウェーデン)
  • Year and Date: 2014-04-11 – 2014-04-16
• [Presentation] Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of over 8000 patients. (2014)
  • Author(s): Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Roupret M, Sharifi N, Jamzadeh A, Kassouf W, Kaushik D, Boorjian SA, Rhogmann F, Noldus J, Masson-Lecomte A, Vordos D, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Fradet Y, Rendon R, Fairey A, Lotan Y, Bachmann A, Zerbib M, Fisch M, Scherr DS, Vickers A, Shariat SF.
  • Organizer: 29th Annual European Association of Urology Congress
  • Place of Presentation: Stockholm(スウェーデン)
  • Year and Date: 2014-04-11 – 2014-04-16
• [Presentation] 局所浸潤性膀胱癌に対する根治的膀胱全摘除術とMVAC併用化学放射線療法の比較検討
  • Author(s): 池田 勝臣、松本 和将、平山 貴博、西 盛宏、田畑 健一、藤田 哲夫、石山 博條、早川 和重、岩村 正嗣
  • Organizer: 第51回日本癌治療学会学術集会
  • Place of Presentation: 京都
• [Presentation] Laparoscopic ureterovesicostomy is a safe and effective procedure using intravesical or extravesical approach in patients with megaureter due to ureterovesical junction obstruction
  • Author(s): Dai Koguchi,Morihiro Nishi,Kazumasa Matsumoto,Takahiro Hirayama,Teppei Oyama,Tetsuo Fujita,Kazunari Yoshida,Masatsugu Iwamura
  • Organizer: 31st World Congress of Endourology & SWL
  • Place of Presentation: New Orleans,USA
• [Presentation] Laparoscopic nephroureterectomy is safe and flexible modality in patients with upper tract urothelial carcinoma irrespective of body mass index
  • Author(s): Takahiro Hirayama,Kazumasa Matsumoto,Morihiro Nishi, Kenichi Tabata,Daisuke Ishi,Tetsuo Fujita,Kazunari Yoshida,Masatugu Iwamura
  • Organizer: 31st World Congress of Endourology & SWL
  • Place of Presentation: New Orleans,USA
• [Presentation] Herpes Simplex Virus-thymidine Kinase遺伝子治療におけるサロゲートマーカーの探索
  • Author(s): 名木 渉人、佐藤 威文、久保 誠、田畑 健一、黒坂 眞二、津村 秀康、平山 貴博、松本 和将、清水 ユリ子、伊東 一郎、小幡 文弥、馬場 志郎、岩村 正嗣
  • Organizer: 第78回日本泌尿器科学会東部総会
  • Place of Presentation: 新潟
• [Presentation] 膀胱癌経過観察中の上部尿路再発についての検討
  • Author(s): 平山 貴博、松本 和将、小林 健太郎、大山 哲平、西 盛宏、石井 大輔、田畑 健一、藤田 哲夫、吉田 一成、岩村 正嗣
  • Organizer: 第78回日本泌尿器科学会東部総会
  • Place of Presentation: 新潟
• [Presentation] Prognostic impact of C-reactive protein kinetics for advanced renal cell carcinoma treated with sunitinib
  • Author(s): Tetsuo Fujita,Masatsugu Iwamura,Takahiro Hirayama,Daisuke Ishii,Ken-ichi Tabata,Kazumasa Matsumoto,Kazunari Yoshida
  • Organizer: 108th Annual Meeting American Urological Association
  • Place of Presentation: San Diego,米国
• [Presentation] 筋層非浸潤性膀胱癌に対する２週間維持療法を用いたBCG膀胱内注入療法の再発予防効果
  • Author(s): 松本和将、入江啓、池田勝臣、津村秀康、藤田哲夫、佐藤威文、岩村正嗣
  • Organizer: 第50回日本癌治療学会学術集会
  • Place of Presentation: 横浜
• [Presentation] Incremental Expression of Serum S100A6 Is Associated with the Detection and Pathologic Feature of Urothelial Carcinoma in the Urinary Bladder
  • Author(s): Nishi M,Matsumoto k,Matsumoto H,Fujita T,Satoh T,Satoh Y,Iwamura M,Baba S
  • Organizer: 32nd Congress of the Societe Internationale d'Urologie
  • Place of Presentation: 福岡
• [Presentation] 膀胱癌における血清uroplakin III発現の臨床的意義について
  • Author(s): 松本和将、松本俊英、入江啓、藤田哲夫、佐藤威文、佐藤雄一、岩村正嗣
  • Organizer: 第71回日本癌学会学術総会
  • Place of Presentation: 札幌
• [Presentation] Systemic T-cell activation following neoadjuvant in situ gene therapy in high-risk prostate cancer patients
  • Author(s): Takefumi Satoh,Makoto Kubo,Ken-ichi Tabata,Shinji Kurosaka,Kazumasa Matsumoto,Tetsuo Fujita Fumiya Obata,Yasutomo Nasu,Hiromi Kumon,Dov Kadmon,Malcolm K Brenner,Timothy C Thompson,Shiro Baba
  • Organizer: 107th Annual Meeting American Urological Association
  • Place of Presentation: Atlanta,USA
• [Presentation] 血清Uroplakin III発現の臨床的意義について
  • Author(s): 松本和将、松本俊英、佐藤絵里奈、池田勝臣、南田諭、藤田哲夫、佐藤威文、岩村正嗣、吉田一成、佐藤雄一、馬場志郎
  • Organizer: 第100回日本泌尿器科学会総会
  • Place of Presentation: 横浜
• [Book] Bladder Cancer: Risk Factors, Emerging Treatment Strategies and Challenges. (2014)
  • Author(s): Matsumoto K, Ikeda M, Hirayama T, Fujita T, Iwamura M.Samantha Haggerty,etc.
  • Total Pages: 174
  • Publisher: Nova Science Publishers, Inc,
• [Book] Hematuria: Etiology, Management and Long-Term Prognosis. (2014)
  • Author(s): Hirayama T, Matsumoto K, Nishi M, Fujita T, Iwamura M,Nikhil Vasdev and G.Boustead,etc.
  • Total Pages: 204
  • Publisher: Nova Science Publishers, Inc,
• [Patent(Industrial Property Rights)] 膀胱癌の診断 (2015)
  • Inventor(s): 松本和将、大草 洋、馬場志郎、小寺義男、前田忠計
  • Industrial Property Rights Holder: 松本和将、大草 洋、馬場志郎、小寺義男、前田忠計
  • Industrial Property Rights Type: 特許
  • Industrial Property Number: 2015-020750
  • Filing Date: 2015-02-20